Marketfy
Financial Data & APIs
Events
Premarket Prep
Membership is Free
What are you waiting for? Sign up now!
Name:
Username available!
Username taken!
Email:
Email available!
Email taken!
Password:
Leave blank:
OR
Free Account Login
Click here to access your premium account
Username or email:
Password:
OR
Forgot password?
Contribute
Login
Join
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
Global Economics
Previews
Reviews
Small-Cap
Cryptocurrency
Penny Stocks
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Catalyst
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Tech
Start-Ups
Fintech
Investing
Best Online Brokers
Personal Finance
Compare Brokers
Ally Invest Review
Binary Options Review
eOption
Etrade Review
Forex.com Review
Interactive Brokers Review
Personal Capital Review
Suretrader Review
TD Ameritrade Review
Tradestation Review
Yewno|Edge Review
Cannabis
Premium
Market Overview
Tickers
Articles
Keywords
Search by keyword...
googlecse
WANT TO CATCH
SNCA
NEWS
BEFORE
IT CHANGES THE STOCK PRICE?
More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
Seneca Biopharma, Inc.
SNCA
:NASDAQ
Add to Watchlist +
Trade
{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists
Sector:
Healthcare
Industry:
Biotechnology
0.9165
-0 (-0.02%)
Data as of Dec 09, 2019
Prev. Close
0.9167
Price Open
0.9229
Volume
8,183
Day's Range
0.9018 - 0.9354
52 Wk Range
0.7 - 13.778
50 Day Moving Avg.
1
PE Ratio
0
Shares Outstanding
3.87M
Market Cap
3.54M
Trade SNCA stock with
recommended broker Ally Invest
. Commissions as low as $3.95.
1d
5d
1m
3m
1y
5y
YTD
Analyst Rating
View All Ratings
Headlines
Press Releases
19 Healthcare Stocks Moving In Friday's Pre-Market Session
Lisa Levin
Fri, 22 Nov 2019 07:47:37 -0500
Seneca Biopharma Shares Tick To Session High On Large Uptick In Volume As Traders Circulate Word Of Int'l. Patent Grant For Alzhemier's Treatment
Benzinga Newsdesk
Thu, 21 Nov 2019 15:04:28 -0500
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
Shanthi Rexaline
Thu, 21 Nov 2019 07:22:05 -0500
Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin
Wed, 20 Nov 2019 10:37:04 -0500
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
Shanthi Rexaline
Wed, 20 Nov 2019 07:25:05 -0500
Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin
Tue, 19 Nov 2019 11:28:53 -0500
The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
Shanthi Rexaline
Tue, 19 Nov 2019 07:56:14 -0500
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
Mon, 18 Nov 2019 13:49:09 -0500
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Fri, 15 Nov 2019 10:43:15 -0500
The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
Shanthi Rexaline
Fri, 08 Nov 2019 08:14:09 -0500
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Seneca Biopharma Reports Third Quarter 2019 Fiscal Results
PRNewswire
Nov 14, 2019
Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit
PRNewswire
Nov 01, 2019
Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit
PRNewswire
Nov 01, 2019
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA
PRNewswire
Oct 31, 2019
{{ story.title }}
{{ story.author }}
{{ story.created }}
Partner Headlines
UCB's bimekizumab success in second late-stage psoriasis study
Seeking Alpha
Nov 15, 2019
Seneca Biopharma reports Q3 results
Seeking Alpha
Nov 14, 2019
Week In Review: BeiGene Forms Blockbuster $2.7 Billion Collaboration With Amgen
Seeking Alpha
Nov 03, 2019
{{ story.title }}
{{ story.author }}
{{ story.created }}
Earnings
View Earnings
Q3 2019
EST
Actual
Surprise
EPS:
Expected
2019-11-14
Rev:
Q4 2019
EST
Actual
Surprise
EPS:
Expected
2020-03-20
Rev:
Company Profile
Read More
Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Its pipeline includes biologics for immunological diseases.
Visit company website
Brokerage Center
Compare All Online Brokerages
Book A Demo
Learn How You Can Succeed In The
Market With Benzinga Pro
Fastest Market News
Real-Time News Alerts
Customizable News Filters
Book A Demo